Graham Capital Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$327K Sell
2,147
-3,266
-60% -$544K 0.01% 871
2026
Q1
$1.14M Buy
+5,413
New +$1.36M 0.03% 402
2025
Q4
– Sell
-1,954
Closed -$603K – 1528
2025
Q3
$603K Sell
1,954
-6,862
-78% -$2.15M 0.01% 551
2025
Q2
$2.77M Buy
8,816
+2,425
+38% +$700K 0.04% 268
2025
Q1
$1.68M Sell
6,391
-4,502
-41% -$1.22M 0.03% 388
2024
Q4
$2.84M Sell
10,893
-513
-4% -$129K 0.04% 222
2024
Q3
$2.65M Buy
11,406
+8,813
+340% +$1.81M 0.05% 217
2024
Q2
$523K Sell
2,593
-13,159
-84% -$2.37M 0.01% 574
2024
Q1
$2.7M Buy
15,752
+10,295
+189% +$1.92M 0.05% 197
2023
Q4
$1.18M Sell
5,457
-17,638
-76% -$3.03M 0.03% 346
2023
Q3
$3.68M Buy
23,095
+20,171
+690% +$4.52M 0.09% 135
2023
Q2
$843K Buy
+2,924
New +$888K 0.02% 410
2022
Q3
– Sell
-3,751
Closed -$817K – 1263
2022
Q2
$817K Buy
+3,751
New +$853K 0.03% 505

Other funds holding PODD

Graham Capital Management's PODD Position: Q2 2026 in Review

Graham Capital Management reduced its Insulet (PODD) stake by 60% in Q2 2026, selling an estimated $544K and leaving 2,147 shares worth $327K. The position accounts for 0.01% of the portfolio, ranked #871.

Graham Capital Management first reported a position in PODD in Q2 2022 and has held it in 13 quarters since. The position peaked at $3.68M in Q3 2023. 731 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Graham Capital Management held 2,147 shares of Insulet worth $327K as of Q2 2026.
  • Graham Capital Management sold 3,266 Insulet shares in Q2 2026, an estimated $544K.
  • Insulet made up 0.01% of Graham Capital Management's portfolio in Q2 2026, its #871 holding.
  • Graham Capital Management first reported a position in Insulet in Q2 2022 and has held it in 13 quarters since.
  • Graham Capital Management's Insulet position peaked at $3.68M in Q3 2023.
  • 731 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.